Nothing Special   »   [go: up one dir, main page]

WO2021220220A1 - Systèmes, dispositifs et procédés de carottage de tissu - Google Patents

Systèmes, dispositifs et procédés de carottage de tissu Download PDF

Info

Publication number
WO2021220220A1
WO2021220220A1 PCT/IB2021/053588 IB2021053588W WO2021220220A1 WO 2021220220 A1 WO2021220220 A1 WO 2021220220A1 IB 2021053588 W IB2021053588 W IB 2021053588W WO 2021220220 A1 WO2021220220 A1 WO 2021220220A1
Authority
WO
WIPO (PCT)
Prior art keywords
tissue
resection device
core
helical
target
Prior art date
Application number
PCT/IB2021/053588
Other languages
English (en)
Inventor
William Cohn
Terry Daglow
Matthew T. KUHN
Jonathan MELCHOR
Theodore Mick
Chris Mills
Steven Nguyen
Jorge SALAZAR
Original Assignee
Ethicon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon, Inc. filed Critical Ethicon, Inc.
Priority to BR112022022100A priority Critical patent/BR112022022100A2/pt
Priority to KR1020227042125A priority patent/KR20230005959A/ko
Priority to CN202180032065.2A priority patent/CN116528780A/zh
Priority to JP2022566610A priority patent/JP2023545883A/ja
Priority to EP21723409.5A priority patent/EP4132388A1/fr
Priority to CA3177320A priority patent/CA3177320A1/fr
Publication of WO2021220220A1 publication Critical patent/WO2021220220A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32—Surgical cutting instruments
    • A61B17/3205—Excision instruments
    • A61B17/32053—Punch like cutting instruments, e.g. using a cylindrical or oval knife
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32—Surgical cutting instruments
    • A61B17/320016—Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1482—Probes or electrodes therefor having a long rigid shaft for accessing the inner body transcutaneously in minimal invasive surgery, e.g. laparoscopy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00809—Lung operations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32—Surgical cutting instruments
    • A61B17/320016—Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes
    • A61B2017/32004—Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes having a laterally movable cutting member at its most distal end which remains within the contours of said end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34—Trocars; Puncturing needles
    • A61B2017/348—Means for supporting the trocar against the body or retaining the trocar inside the body
    • A61B2017/3482—Means for supporting the trocar against the body or retaining the trocar inside the body inside
    • A61B2017/3484—Anchoring means, e.g. spreading-out umbrella-like structure
    • A61B2017/3488—Fixation to inner organ or inner body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00529—Liver
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00541—Lung or bronchi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00601—Cutting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/1405—Electrodes having a specific shape
    • A61B2018/1425—Needle
    • A61B2018/1432—Needle curved
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3904—Markers, e.g. radio-opaque or breast lesions markers specially adapted for marking specified tissue
    • A61B2090/3908—Soft tissue, e.g. breast tissue

Definitions

  • Cancer is not a single disease, but rather a collection of related diseases that can start essentially anywhere in the body.
  • the body Common amongst all types of cancer is that the body’s cells begin to divide without stopping, proliferating and potentially spreading into surrounding tissues.
  • cells grow and divide to form new cells as required by the body and when they become damaged or old, they die, and new cells replace the damaged or old cells; however, cancer interrupts this process.
  • the cells With cancer, the cells become abnormal, and cells that should die do not and new cells form when they are not needed. These new cells can reproduce or proliferate without stopping and may form growths called tumors.
  • Cancerous tumors are malignant, which means they can spread into or invade surrounding healthy tissue. In addition, cancer cells can break off and travel to remote areas in the body through blood or in the lymph system. Benign tumors, unlike malignant tumors, do not spread or invade surrounding tissue; however, they may grow large and cause damage. Both malignant and benign tumors may be removed or treated. Malignant tumors tend to grow back whereas benign tumors can grow back but are much less likely to do so.
  • Cancer is a genetic disease in that it is caused by changes in the genes that control the ways that cells function, especially in how they grow and divide. Genetic changes that cause cancer may be inherited or they may arise over an individual’s lifetime as a result of errors that occur as cells divide or because of damage to DNA caused by certain environmental exposure, for example, industrial/commercial chemicals and ultraviolet light.
  • the genetic changes that may cause cancer tend to affect three types of genes; namely proto-oncogenes which are involved in normal cell growth and division, tumor suppressor genes which are also involved in controlling cell growth and division, and DNA repair genes which, as the name implies, are involved in repairing damaged DNA.
  • cancer More than one-hundred distinct types of cancer have been identified.
  • the type of cancer may be named for the organ or tissue where the cancers arise, for example, lung cancer, or the type of cell that formed them, for example squamous cell cancer.
  • Cancer is a leading cause of death both in the United States and world-wide. According to the World Health Organization, the number of new cancer cases will rise to twenty-five (25) million per year over the next two decades.
  • Lung cancer is one of the most common cancers today. According to the World Cancer Report 2014 from the World Health Organization, lung cancer occurred in 14 million people and resulted in 8.8 million deaths world- wide, making it the most common cause of cancer-related death in men and the second most common cause of cancer-related death in women. Lung cancer or lung carcinoma is a malignant lung tumor that if left untreated can metastasize into neighboring tissues and organs. The majority of lung cancer is caused by long term tobacco smoking; however, about 10 to 15 percent of lung cancer cases are not tobacco related. These non-tobacco cases are most often caused by a combination of genetic factors and exposure to certain environmental conditions, including radon gas, asbestos, second-hand tobacco smoke, other forms of air pollution, and other agents. The chance of surviving lung cancer as well as other forms of cancer depends on early detection and treatment.
  • a core of tissue may have a prescribed (e.g., pre-defined) shape (e.g., columnar) and dimension based on a coring apparatus.
  • a coring apparatus may be used to core the same or substantially the same shaped tissue core in a repeatable manner.
  • Such coring may be distinguished from other tissue removal, for example using scissors or scalpel, where the cut tissue will not have a pre-defined shape or dimensions.
  • a method for coring tissue may comprise disposing a tissue resection device at a target tissue site, causing the tissue resection device to resect a core of tissue from the target tissue site, and removing the core of tissue from the body, wherein the removing the core of tissue from the body creates a core cavity at the target tissue site.
  • the core of tissue comprises at least a portion of a tissue lesion.
  • the resecting the core of tissue from the target tissue site may comprise mechanical transection.
  • the resecting the core of tissue from the target tissue site may comprise the delivery of radiofrequency energy.
  • the resecting the core of tissue from the target tissue site may comprise mechanical compression and the delivery of radiofrequency energy.
  • the resecting the core of tissue from the target tissue site may comprise transection with an energized wire.
  • the resecting the core of tissue from the target tissue site may comprise one of more of mechanical compression, the delivery of radiofrequency energy, the delivery of microwave energy, the delivery of ultrasonic energy, or transection with an energized wire.
  • the resection device may be configured for one or more of mechanical compression, the delivery of radiofrequency energy, the delivery of microwave energy, the delivery of ultrasonic energy, or transection with an energized wire.
  • Methods for coring tissue may further comprise inserting a sleeve into the core cavity to support a wall of the core cavity.
  • Methods for coring tissue may further comprise delivering radiofrequency energy to at least a portion of a wall defining the core cavity.
  • Methods for coring tissue may further comprise delivering chemotherapy to at least a portion of a wall defining the core cavity.
  • Methods for coring tissue may further comprise delivering microwave energy to at least a portion of a wall defining the core cavity.
  • Methods for coring tissue may further comprise delivering thermal energy to at least a portion of a wall defining the core cavity.
  • Methods for coring tissue may further comprise delivering ultrasonic energy to at least a portion of a wall defining the core cavity.
  • Methods for coring tissue may further comprise sealing biological fluid vessels.
  • the sealing biological fluid vessels may minimize flow of biological fluids into the cavity core.
  • the sealing may be effected using at least mechanical compression.
  • the sealing may be effected using at least radiofrequency energy.
  • the sealing may be effected using at least microwave energy.
  • the sealing may be effected using at least ultrasonic energy.
  • the sealing may be effected using one or more of compression or delivery of energy such as radiofrequency, microwave, ultrasonic, or thermal energy.
  • a lung needle biopsy is typically performed when an abnormality is found on an imaging test, for example, an X-ray or CAT scan.
  • a fine needle is used to remove sample of lung tissue for examining under a microscope to determine the presence of abnormal cells.
  • Tissue diagnosis is challenging in small ( ⁇ 6mm) and intermediate (6- 12mm) nodules.
  • CT guided biopsy of peripheral lesions either through the chest wall (80%) or by means of a bronchoscope (20%) yields only a .001 -.002 cm2 of diagnostic tissue, and as such, cancer, when present, is only successfully identified in 60% of small and intermediate nodules.
  • bronchoscopic techniques and technology continue to evolve, biopsy accuracy, specificity, and sensitivity will always be limited when dealing with small and intermediate nodules in the periphery of the lung.
  • a second procedure may be performed to remove the lesion and then followed up with chemotherapy and/or radiation.
  • the second procedure most likely involves lung surgery. These procedures are typically done through an incision between the ribs. There are a number of possible procedures depending on the state of the cancer.
  • Video-assisted thoracic surgery is a less invasive procedure for certain types of lung cancer. It is performed through small incisions utilizing an endoscopic approach and is typically utilized for performing wedge resections of smaller lesions close to the surface of a lung. In a wedge resection, a portion of the lobe is removed. In a sleeve resection, a portion of a large airway is removed thereby preserving more lung function.
  • the recovery may take from weeks to months. With a thoracotomy, spreading of the ribs is required, thereby increasing postoperative pain. Although video-assisted thoracic surgery is less invasive, there can still be a substantial recovery period. In addition, once the surgery is complete, full treatment may require a system chemotherapy and/or radiation treatment.
  • a fine needle biopsy may not prove to be totally diagnostic.
  • the fine needle biopsy procedure involves guiding a needle in three-dimensional space under two-dimensional imaging. Accordingly, the doctor may miss the lesion, or even if he or she hits the correct target, the section of the lesion that is removed through the needle may not contain the cancerous cells or the cells necessary to assess the aggressiveness of the tumor.
  • a needle biopsy removes enough tissue to create a smear on a slide.
  • the device of the present disclosure is designed to remove the entire lesion, or a substantial portion of it, while minimizing the amount of healthy lung tissue removal. This offers a number of advantages.
  • the entire lesion may be examined for a more accurate diagnosis without confounding sampling error, loss of cell packing or gross architecture.
  • a secondary procedure as described above may not be required.
  • localized chemotherapy and/or energy-based tumor extirpation, such as radiation, may be introduced via the cavity created by the lesion removal.
  • the disclosure defines a method for removing a tissue lesion including anchoring to the tissue lesion; creating a channel in the tissue leading to the tissue lesion; creating a tissue core including the tissue lesion; ligating the tissue core at a ligation point downstream from the tissue lesion; amputating the tissue core form the tissue between the ligation point and the tissue lesion; and removing the tissue core from the channel.
  • the sleeve may be inserted in the channel prior to or after removing the tissue core.
  • the sleeve may also be anchored to the tissue.
  • a localized treatment may be delivered through the sleeve.
  • creating a tissue core includes cauterizing and cutting tissue.
  • Ligating tissue may include tissue may include cauterizing tissue at a specific location known as the ligation point. Amputation of the tissue core may be performed with a snare, an energized wire or any other device capable of slicing tissue.
  • the tissue core is created by first sealing blood vessels then slicing tissue to form the core.
  • Figure 1 depicts a tissue resection device in accordance with an embodiment of the present disclosure.
  • Figure 2 illustrates a sectional view of the tissue resection device of Figure 1.
  • Figure 3 shows a sectional view of a tissue resection device in accordance with an embodiment of the present disclosure.
  • Figure 4 depicts a sectional view of a tissue resection device in accordance with an embodiment of the present disclosure.
  • Figure 5 illustrates an exemplary anchor that may be employed in a lesion removal method in accordance with an embodiment of the present disclosure.
  • Figure 6 shows a series of incision blades for use in a lesion removal method in accordance with an embodiment of the present disclosure.
  • Figure 7 displays tissue dilators suitable for use in a lesion removal method in accordance with an embodiment of the present disclosure.
  • Figure 8 shows a flow diagram of an example method for coring and for sealing tissue.
  • the present disclosure relates to systems and methods for coring tissue. Various tissue and sites may benefit from the disclosed systems and methods.
  • a core of tissue may have a prescribed (e.g., pre-defined) shape (e.g., columnar) and dimension based on a coring apparatus.
  • a coring apparatus may be used to core the same or substantially the same shaped tissue core in a repeatable manner.
  • Such coring may be distinguished from other tissue removal, for example using scissors or scalpel, where the cut tissue will not have a pre-defined shape or dimensions.
  • the present disclosure relates to methods and systems for coring tissue.
  • Methods for coring tissue may comprise disposing a tissue resection device at a target tissue site, causing the tissue resection device to resect a core of tissue from the target tissue site, and removing the core of tissue from the body, wherein the removing the core of tissue from the body creates a core cavity at the target tissue site.
  • the core of tissue comprises at least a portion of a tissue lesion.
  • the resecting the core of tissue from the target tissue site may comprise mechanical transection.
  • the resecting the core of tissue from the target tissue site may comprise the delivery of radiofrequency energy.
  • the resecting the core of tissue from the target tissue site may comprise mechanical compression and the delivery of radiofrequency energy.
  • the resecting the core of tissue from the target tissue site may comprise transection with an energized wire.
  • the resecting the core of tissue from the target tissue site may comprise one of more of mechanical compression, the delivery of radiofrequency energy, the delivery of microwave energy, the delivery of ultrasonic energy, or transection with an energized wire.
  • Other resection devices and procedures may be used.
  • the resection device may be configured for one or more of mechanical compression, the delivery of radiofrequency energy, the delivery of microwave energy, the delivery of ultrasonic energy, or transection with an energized wire.
  • the present disclosure relates to methods and systems for coring tissue and sealing the core cavity created by removing the tissue core.
  • Such methods may comprise disposing a fill material in the core cavity.
  • Methods may comprise applying pressure to a portion of the core cavity such as to a wall defining the core cavity.
  • Methods may comprise ablating a portion of the core cavity such as a wall defining the core cavity.
  • Methods may comprise causing a cavity closure device, such as suture thread, a stapling device, an ultrasonic tissue sealing device, a bipolar radiofrequency sealing device, or any combination thereof to close the tissue cavity.
  • Methods may comprise disposing a cavity sealing material, such as a tissue graft, a hemostatic patch, a hemostatic agent such as fibrin or thrombin, a biological adhesive material such as Dermabond®, or any combination thereof to close the tissue cavity.
  • Methods may comprise coring and sealing blood vessel simultaneously as coring procedure is implemented.
  • radiofrequency energy may be provided between the coil and anvil electrodes.
  • a coil may be rotated into a target site, an anvil electrode may be cause to close against the coil, a radiofrequency energy may be used to seal areas adjacent the target site, and tissue may be cored using a cutting blade.
  • tissue may be cored using a cutting blade.
  • ligation e.g., with another set of electrodes
  • a mechanical ligation line may be deployed to finish the coring process so that cored tissue can be removed, leaving the cored cavity ready for any subsequent step.
  • Methods may comprise any combination or permutation of: 1) disposing an anchoring device into a tissue cavity, 2) disposing a tissue access port into the tissue cavity, 3) disposing a tissue sealing device into the tissue cavity (with or without a tissue access port, with or without guidance from an anchoring device), 4) causing the tissue sealing device to seal at least a portion of the tissue cavity, 5) introducing a fill material into the tissue cavity (with or without a fill material delivery device, with or without being preceded by disposing a tissue sealing device into the tissue cavity, with or without removing the tissue sealing device after sealing at least a portion of the tissue cavity, with or without a tissue access port), 6) disposing a cavity sealing material adjacent to the tissue cavity (with or without being preceded by disposing a tissue sealing device into the tissue cavity, with or without removing the tissue sealing device after sealing at least a portion of the tissue cavity, with or without being preceded by introducing a fill material into the tissue cavity), 7) disposing a cavity closure device adjacent to the tissue, and
  • methods may be used to core and/or seal tissue at various target sites.
  • a lung is used as an illustrative example, it should not be so limiting, as other target sites may be punctured or actively cored and may benefit from the disclosed sealing methods.
  • Various methods, devices, and systems may be used to core or remove tissue.
  • a method for removing a tissue lesion may comprise introducing a tissue resection device to a target tissue site, causing the tissue resection device to resect a core of tissue from the target tissue site, and removing the core of tissue from the body.
  • the core of tissue may comprises at least a portion of a tissue lesion.
  • a method may further comprise creating a core cavity at the target tissue site.
  • a method may further comprise inserting a sleeve into the core cavity.
  • a method may further comprise delivering radiofrequency energy through the core cavity.
  • a method may further comprise delivering chemotherapy through the core cavity.
  • a method may further comprise delivering microwave radiation through the core cavity.
  • a method may further comprise delivering thermal energy through the core cavity.
  • a method may further comprise delivering ultrasonic energy through the core cavity.
  • the tissue resection device may be configured for the delivery of radiofrequency energy.
  • the tissue resection device may be configured for mechanical transection.
  • the tissue resection device may comprise mechanical compression and the delivery of radiofrequency energy.
  • a method may further comprise amputating the core of tissue from the target tissue site.
  • the means for amputation of the core of tissue may comprise mechanical transection.
  • the means for amputation of the core of tissue may comprise the delivery of radiofrequency energy.
  • the means for amputation of the core of tissue may comprise mechanical compression and the delivery of radiofrequency energy.
  • the means for amputation of the core of tissue may comprise transection with an energized wire. Other devices may be used.
  • a method for removing a core of tissue may comprise introducing a tissue resection device to a target tissue site, causing the tissue resection device to resect a core of tissue from the target tissue site, and removing the core of tissue from the body.
  • a method may further comprise creating a core cavity at the target tissue site.
  • a method may further comprise inserting a sleeve into the core cavity.
  • a method may further comprise delivering radiofrequency energy through the core cavity.
  • a method may further comprise delivering chemotherapy through the core cavity.
  • a method may further comprise delivering microwave radiation through the core cavity.
  • a method may further comprise delivering thermal energy through the core cavity.
  • a method may further comprise delivering ultrasonic energy through the core cavity.
  • the tissue resection device may be configured for the delivery of radiofrequency energy.
  • the tissue resection device may be configured for mechanical transection.
  • the tissue resection device may be configured for mechanical compression and the delivery of radiofrequency energy.
  • a method may further comprise amputating the core of tissue from the target tissue site.
  • the means for amputation of the core of tissue may comprise mechanical transection.
  • the means for amputation of the core of tissue may comprise the delivery of radiofrequency energy.
  • the means for amputation of the core of tissue may comprise mechanical compression and the delivery of radiofrequency energy.
  • the means for amputation of the core of tissue may comprise transection with an energized wire.
  • a method for removing a core of tissue may comprise introducing a tissue resection device to a target tissue site.
  • the tissue resection device may comprise one or more of: a first clamping element comprising a helical coil and a first electrode, or a second clamping element comprising a second electrode. Where a second clamping element is included, the second clamping element may be positioned to oppose at least a portion of the first clamping element.
  • the method may further comprise causing the tissue resection device to resect a core of tissue from the target tissue site and removing the core of tissue from the body.
  • a method may further comprise creating a core cavity at the target tissue site.
  • a method may further comprise inserting a sleeve into the core cavity.
  • a method may further comprise delivering radiofrequency energy through the core cavity.
  • a method may further comprise delivering chemotherapy through the core cavity.
  • a method may further comprise delivering microwave radiation through the core cavity.
  • a method may further comprise delivering thermal energy through the core cavity.
  • a method may further comprise delivering ultrasonic energy through the core cavity.
  • the tissue resection device may be configured for resecting the core of tissue comprises the delivery of radiofrequency energy.
  • the tissue resection device may be configured for resecting the core of tissue comprises mechanical transection.
  • the tissue resection device may be configured for resecting the core of tissue comprises mechanical compression and the delivery of radiofrequency energy.
  • a method may further comprise amputating the core of tissue from the target tissue site.
  • the means for amputation of the core of tissue may comprise mechanical transection.
  • the means for amputation of the core of tissue may comprise the delivery of radiofrequency energy.
  • the means for amputation of the core of tissue may comprise mechanical compression and the delivery of radiofrequency energy.
  • the means for amputation of the core of tissue may comprise transection with an energized wire.
  • a method for sealing biological fluid vessels may comprise piercing a target tissue site containing a least a portion of at least one target biological fluid vessel with a helical tissue sealing mechanism, wherein the helical tissue sealing mechanism comprises: a helical piercing element and a clamping element.
  • the method may comprise causing the helical tissue sealing mechanism to apply mechanical compression to at least one target biological fluid vessel and delivering energy to seal at least one target biological fluid vessel.
  • the helical piercing element may comprise the clamping element.
  • the mechanical compression may be applied between the helical piercing element and the clamping element.
  • a method may further comprise a second clamping element.
  • the mechanical compression may be applied between the first and second clamping elements.
  • the delivered energy may comprise monopolar radiofrequency energy.
  • the delivered energy may comprise bipolar radiofrequency energy.
  • the delivered energy may comprise thermal energy.
  • the delivered energy comprises ultrasonic energy.
  • a method for sealing biological fluid vessels may comprise piercing a target tissue site with a helical piercing element, adjusting the pitch of the helical piercing element to apply mechanical compression to the target tissue, and delivering energy to seal at least one biological fluid vessel in the target tissue.
  • the helical piercing element may comprise a plurality of tissue sealing electrodes.
  • the delivered energy may comprise monopolar radiofrequency energy.
  • the delivered energy may comprise bipolar radiofrequency energy.
  • the delivered energy may comprise thermal energy.
  • the delivered energy may comprise ultrasonic energy.
  • a tissue resection apparatus may comprise a first clamping element comprising a helical coil, a second clamping element, the second clamping element being positioned to oppose at least a portion of the first clamping element, a first and second electrode configured for the delivery of radiofrequency energy for sealing tissue, and a cutting element configured for the transection of at least a portion of the sealed tissue.
  • a tissue resection device may further comprise: a first actuator operable to actuate the first or second clamping element to apply mechanical compression to tissue and a second actuator operable to actuate the cutting element to transect tissue.
  • the helical coil may include first and second contiguous coil segments.
  • the first coil segment may comprise a generally planar open ring.
  • the first coil segment may be helical and may have a pitch of zero.
  • the second coil segment may be helical and may have a non-zero pitch.
  • the second coil segment may have a variable pitch.
  • the first coil segment may be helical and may have a first pitch and the second coil segment may be helical and may have a second pitch, and at least one of the first and second pitches may be variable.
  • the first electrode may be comprised by at least a portion of the first clamping element.
  • the second electrode may be comprised by at least a portion of the second clamping element.
  • the helical coil may comprise a blunt tip.
  • the first and second electrodes may comprise surface profiles that are matching or substantially matching. At least a portion of the cutting element may comprise a sharpened edge.
  • the cutting element may comprise at least one electrode configured for the delivery of radiofrequency energy.
  • the cutting element may comprise an ultrasonic blade.
  • the tissue resection device may further comprise a second cutting element configured for the amputation the core of tissue from the target tissue site. At least a portion of the second cutting element may comprise a sharpened edge.
  • the second cutting element may comprise at least one electrode configured for the delivery of radiofrequency energy.
  • the second cutting element may comprise an energized wire.
  • the second cutting element may comprises a suture.
  • the tissue resection device may further comprise an actuator operable to actuate the second cutting element to transect tissue.
  • a tissue resection apparatus may comprise a first clamping element having a helical coil disposed on a distal end, a second clamping element, the second clamping element being positioned to oppose at least a portion of the first clamping element, a first and second electrode configured for the delivery of radiofrequency energy for sealing tissue, and a cutting element configured for the transection of at least a portion of the sealed tissue.
  • the tissue resection device may further comprise a first actuator operable to actuate the first or second clamping element to apply mechanical compression to tissue and a second actuator operable to actuate the cutting element to transect tissue.
  • the helical coil may comprise first and second contiguous coil segments.
  • the first coil segment comprises a generally planar open ring.
  • the first coil segment may be helical and may have a pitch of zero.
  • the second coil segment may be helical and may have a non- zero pitch.
  • the second coil segment may have a variable pitch.
  • the first coil segment may be helical and may have a first pitch and the second coil segment may be helical and may have a second pitch, and at least one of the first and second pitches may be variable.
  • the first electrode may be comprised by at least a portion of the helical coil.
  • the first electrode may be comprised by at least a portion of the first clamping element.
  • the second electrode may be comprised by at least a portion of the second clamping element.
  • the helical coil may comprise a blunt tip.
  • the first and second electrodes may comprise surface profiles that are matching or substantially matching.
  • the cutting element may comprise a sharpened edge.
  • the cutting element may comprise at least one electrode configured for the delivery of radiofrequency energy.
  • the cutting element may comprise an ultrasonic blade.
  • the tissue resection device may further comprise a second cutting element configured for the amputation the core of tissue from the target tissue site. At least a portion of the second cutting element may comprise a sharpened edge.
  • the second cutting element may comprise at least one electrode configured for the delivery of radiofrequency energy.
  • the second cutting element may comprise an energized wire.
  • the second cutting element may comprise a suture.
  • the tissue resection device may further comprise an actuator operable to actuate the second cutting element to transect tissue.
  • a tissue resection apparatus may comprise a first clamping element comprising a helical coil and a first electrode, and a second clamping element comprising a second electrode, the second clamping element being positioned to oppose at least a portion of the first clamping element.
  • the first and second clamping elements may be configured for: (a) the delivery of radiofrequency energy for sealing tissue, and (b) the application of mechanical compression for the transection of tissue.
  • the tissue resection device may further comprise a first actuator operable to actuate the first or second clamping element to apply mechanical compression to tissue and a second actuator operable to actuate the cutting element to transect tissue.
  • the helical coil may comprise first and second contiguous coil segments.
  • the first coil segment may comprise a generally planar open ring.
  • the first coil segment may be helical and may have a pitch of zero.
  • the second coil segment may be helical and may have a non-zero pitch.
  • the second coil segment may have a variable pitch.
  • the first coil segment may be helical and may have a first pitch and the second coil segment may be helical and may have a second pitch, and at least one of the first and second pitches may be variable.
  • the first electrode may be comprised by at least a portion of the helical coil.
  • the first electrode may be comprised by at least a portion of the first clamping element.
  • the second electrode may be comprised by at least a portion of the second clamping element.
  • the helical coil may comprise a blunt tip.
  • the first and second electrodes may comprise surface profiles that are matching or substantially matching. At least a portion of the cutting element may comprise a sharpened edge.
  • the cutting element may comprise at least one electrode configured for the delivery of radiofrequency energy.
  • the cutting element may comprise an ultrasonic blade.
  • the tissue resection device may further comprise a second cutting element configured for the amputation the core of tissue from the target tissue site. At least a portion of the second cutting element may comprise a sharpened edge.
  • the second cutting element may comprise at least one electrode configured for the delivery of radiofrequency energy.
  • the second cutting element may comprise an energized wire.
  • the second cutting element may comprise a suture.
  • the tissue resection device may further comprise an actuator operable to actuate the second cutting element to transect tissue.
  • a surgical instrument system for the resection of tissue may comprise an end effector operable to cut and seal tissue, wherein the end effector and a generator configured to provide power to the end effector having the first and second electrodes for sealing tissue.
  • the end effector may comprise a first clamping element comprising a helical coil, a second clamping element, the second clamping element being positioned to oppose at least a portion of the first clamping element, a first and second electrode configured for the delivery of radiofrequency energy for sealing tissue, and a cutting element configured for the transection of at least a portion of the sealed tissue.
  • the surgical instrument system may further comprise a controller in communication with the generator, wherein the controller is configured to control the generator to provide radiofrequency energy sufficient to seal tissue to the first and second electrodes of the end effector, based on at least one sensed operating condition of the end effector.
  • the controller may be configured to sense the presence of tissue at the end effector.
  • the controller may be configured to sense the presence of tissue at the end effector based on a measured impedance level associated with the first and second electrodes.
  • the controller may be configured to sense an amount of force applied to at least one of the first or second clamping elements to detect the presence of tissue at the end effector.
  • the controller may be configured to sense the position of the cutting element relative to at least one of the first or second clamping elements.
  • the controller may be configured to control the generator to provide radiofrequency energy at the end effector when the second actuator is actuated and no tissue is sensed at the end effector.
  • the controller may be configured to control the generator to provide a continuous amount of radiofrequency energy.
  • the controller may be configured to control the generator to automatically provide an increase or decrease in the amount of radiofrequency energy.
  • the system may further comprise: a first actuator operable to actuate the first or second clamping element to apply mechanical compression to tissue; and; a second actuator operable to actuate the cutting element to transect tissue.
  • the helical coil may comprise first and second contiguous coil segments, the first coil segment including the first electrode.
  • the first coil segment may comprise a generally planar open ring.
  • the first coil segment may be helical and may have a pitch of zero.
  • the second coil segment may be helical and may have a non-zero pitch.
  • the second coil segment may have a variable pitch.
  • the first coil segment may be helical and may have a first pitch and the second coil segment may be helical and may have a second pitch, and at least one of the first and second pitches may be variable.
  • the first electrode may be comprised by at least a portion of the helical coil.
  • the first electrode may be comprised by at least a portion of the first clamping element.
  • the second electrode may be comprised by at least a portion of the second clamping element.
  • the helical coil may comprise a blunt tip.
  • the first and second electrodes may comprise surface profiles that are matching or substantially matching.
  • the cutting element may comprise a sharpened edge.
  • the cutting element may comprise at least one electrode configured for the delivery of radiofrequency energy.
  • the cutting element may comprise an ultrasonic blade.
  • the tissue resection device may further comprise a second cutting element configured for the amputation the core of tissue from the target tissue site. At least a portion of the second cutting element may comprise a sharpened edge.
  • the second cutting element may comprise at least one electrode configured for the delivery of radiofrequency energy.
  • the second cutting element may comprise an energized wire.
  • the second cutting element may comprise a suture.
  • the tissue resection device may further comprise an actuator operable to actuate the second cutting element to transect tissue.
  • a tissue resection apparatus may comprise a first clamping element comprising a helical coil, a second clamping element, the second clamping element being positioned to oppose at least a portion of the first clamping element, a first and second electrode configured for the delivery of radiofrequency energy for sealing tissue, a first cutting element configured for the transection of at least a portion of the sealed tissue, a first and second ligating element, and a second cutting element positioned between said first and second ligating elements.
  • the tissue resection device may further comprise a first actuator operable to actuate the first or second clamping element to apply mechanical compression to tissue, and a second actuator operable to actuate the cutting element to transect tissue.
  • the helical coil may comprise first and second contiguous coil segments.
  • the first coil segment may comprise a generally planar open ring.
  • the first coil segment may be helical and may have a pitch of zero.
  • the second coil segment may be helical and may have a non- zero pitch.
  • the second coil segment may have a variable pitch.
  • the first coil segment may be helical and may have a first pitch and the second coil segment may be helical and may have a second pitch, and at least one of the first and second pitches may be variable.
  • the first electrode may be comprised by at least a portion of the helical coil.
  • the first electrode may be comprised by at least a portion of the first clamping element.
  • the second electrode may be comprised by at least a portion of the second clamping element.
  • the helical coil may comprise a blunt tip.
  • the first and second electrodes may comprise surface profiles that are matching or substantially matching. At least a portion of the cutting element may comprise a sharpened edge.
  • the cutting element may comprise at least one electrode configured for the delivery of radiofrequency energy.
  • the cutting element may comprise an ultrasonic blade.
  • the tissue resection device may further comprise a second cutting element configured for the amputation the core of tissue from the target tissue site. At least a portion of the second cutting element may comprise a sharpened edge.
  • the second cutting element may comprise at least one electrode configured for the delivery of radiofrequency energy.
  • the second cutting element may comprise an energized wire.
  • the second cutting element may comprise a suture.
  • the tissue resection device may further comprise an actuator operable to actuate the second cutting element to transect tissue.
  • a tissue sealing mechanism may comprise a helical coil with a generally obround cross section and a tapered point disposed at a distal end, a first and second helical tissue sealing surface, wherein the first and second helical tissue sealing surfaces are provided by the parallel planar surfaces of the helical coil, a first electrode disposed on the first helical tissue sealing surface, and a second electrode disposed on the second helical tissue sealing surface, wherein the first and second electrodes are configured to apply bipolar radiofrequency energy for sealing tissue.
  • the helical coil may comprise first and second contiguous coil segments.
  • the helical coil may comprise a blunt tip.
  • the first and second electrodes may have surface profiles that are substantially matching.
  • the first and second helical tissue sealing surfaces may further comprise a plurality of electrodes configured for the delivery of bipolar radiofrequency energy.
  • FIGS. 1-7 show examples devices that may be used to effect a coring process, as described herein.
  • a resection device of the present disclosure may comprise an energy-based arrangement capable of penetrating tissue towards a target lesion.
  • tissue resection device 1100 includes an outer tube 1105 is provided having a distal edge profile and having an inner diameter IDouter.
  • a coil 1110 is attached to the outer tube 1105 where the coil turns are spaced from and opposed to a distal end of the outer tube 1105.
  • the coil 1110 preferably has a slightly blunted tip 1115 to minimize the possibility that it will penetrate through a blood vessel while being sufficiently sharp to penetrate tissue such as pleura and parenchyma.
  • the coil 1110 may take the form of a helix having a constant or variable pitch.
  • the coil 1110 may also have a variable cross- sectional geometry.
  • An electrode 1130 is disposed on a surface or embedded within the coil 1110 [0049]
  • the coil 1110 may include a plurality of contiguous coil segments, e.g., coil segments 1120 and 1125.
  • Coil segment 1120 comprises a helical member having a pitch of zero, e.g., a generally planar open ring structure, having an inner diameter IDcoil and an outer diameter ODcoil.
  • Coil segment 1125 comprises a helical structure of constant or variable pitch and constant or variable cross-sectional geometry.
  • the electrode 1130 may be disposed on a surface of or embedded in coil segment 1120.
  • a central tube 1200 having a distal end with an edge profile comprising one or more surface segments and having an outer diameter ODcentral and an inner diameter IDcentral.
  • an electrode 1205 is disposed on or embedded within at least one of the surface segments.
  • the central tube 1200 is slidably disposed within the outer tube 1105 and positioned such that electrode 1205 opposes and overlaps at least a portion of electrode 1130.
  • the space between electrode 1205 and electrode 1130 is referred to as the tissue clamping zone.
  • ODcentral is about equal to ODcoil. Accordingly, the central tube 1200 may be advanced through the tissue clamping zone towards the coil 1110 such that electrode 1205 abuts electrode 1130.
  • a cutting tube 1300 is slidably disposed within central tube 1200.
  • the distal end of the cutting tube 1300 is provided with a knife edge to facilitate tissue cutting.
  • the resection device 1100 may be inserted into tissue and the outer tube 1105 may be advanced a predetermined distance towards a target.
  • Coil segment 1125 allows the device to penetrate the tissue in a manner similar to a cork screw. As coil segment 1125 penetrates tissue, any vessel in its path is either moved planar to the coil segment 1120 or pushed away from the coil 1100 for subsequent turns.
  • the coil tip 1115 is made blunt enough to minimize chances that it will penetrate through a blood vessel while still sharp enough to penetrate certain tissue such as the lung pleura and parenchyma.
  • the central tube 1200 may then be advanced a predetermined distance towards the target. Any vessels that are disposed in the tissue clamping zone will be clamped between electrode 1130 and electrode 1205.
  • the vessels can then be sealed by the application of bipolar energy to electrode 1130 and electrode 1205.
  • the cutting tube 1300 is advanced to core the tissue to the depth that the outer tube 1105 has reached. The sealing and cutting process can be repeated to create a core of desired size.
  • the resection device 1100 may be further configured to dissect a target lesion and seal tissue proximate the dissection point.
  • the central tube 1200 is provided with a ligation snare 1230, first and second ligation electrodes 1215 and 1220, and an amputation snare 1225.
  • the word “snare” refers to a flexible line, e.g., a string or a wire.
  • the inner wall surface of the central tube 1200 includes upper and lower circumferential grooved pathways 1212 and 1214 disposed proximate the distal end.
  • the first and second ligation electrodes 1215 and 1220 are disposed on the inner wall of the central tube 1200 such that lower circumferential groove 1214 is between them.
  • Upper grooved pathway 1212 is disposed axially above the ligation electrodes 1215 and 1220.
  • the ligation snare 1230 is disposed in lower circumferential groove 1214 and extends through the central tube 1200 and axially along the outer wall surface to a snare activation mechanism (not shown).
  • Amputation snare 1225 is disposed in upper circumferential groove 1212 and extends through the central tube 1200 and axially along the outer wall surface to a snare activation mechanism (not shown).
  • the outer surface of the central tube 1200 may be provided with a plurality of axially extending grooved pathways which receive the amputation snare 1225, the ligation snare 1230 and are in communication with upper and lower circumferential grooved pathways 1212 and 1214.
  • electrode leads for the ligation electrodes 1215 and 1220 may extend to an energy source via the axially extending grooved pathways.
  • the resection device 1100 of this embodiment can detach and seal the tissue core.
  • the cutting tube 1300 may be retracted to expose the ligation snare 1230 which is preferably made of flexible line, e.g., suture.
  • the ligation snare 1230 may be engaged to snag tissue and pull tissue against the inner wall surface between first and second ligation electrodes 1215 and 1220. Bipolar energy is then applied to first and second electrodes 1215 and 1220 to seal, i.e., cauterize, the tissue.
  • the cutting tube 1300 may be further retracted to expose the amputation snare 1225 which may then be activated to sever the tissue core upstream from the point where the tissue was sealed (ligation point).
  • the amputation snare 1225 has a smaller diameter than that of the ligation snare 1230. The smaller diameter facilitates tissue slicing. Accordingly, the resection device 1100 according to this embodiment both creates a tissue core and disengages the core from surrounding tissue.
  • the resection device 1100 of the present disclosure is provided with a single snare disposed between the ligation electrodes which both ligates and cuts tissue.
  • the single snare first pulls tissue against the inner wall surface of the central tube 1200 between the ligation electrodes 1215 and 1220 Bipolar energy is then applied to the first and second electrodes 1215 and 1220 to seal, i.e., cauterize, the tissue. Once sealed, the snare is further pulled to sever the tissue core.
  • cutting and sealing may be performed without employing electrodes.
  • the ligation snare 1230 includes a set of knots 1235 and 1240 which tighten under load, shown, for example, in Figure 4
  • Ligation is performed by retracting the cutting tube 1300 to expose the ligation snare 1230 and activating the ligation snare 1230 which lassos tissue as the ligation knot tightens. Once the tissue is lassoed, the cutting tube 1300 may be further retracted to expose amputation snare 1225 which may then be activated to sever the tissue core upstream from the point where the point where the tissue was lassoed.
  • the present disclosure also contemplates a method and system for using the resection device to remove tissue lesions, for example, lung lesions.
  • the method generally comprises anchoring the lesion targeted for removal, creating a channel in the tissue leading to the target lesion, creating a tissue core which includes the anchored lesion, ligating the tissue core and sealing the surrounding tissue, and removing the tissue core including the target lesion from the channel.
  • Anchoring may be performed by any suitable structure for securing the device to the lung.
  • a channel may be created to facilitate insertion of the resection device 1100.
  • the channel may be created by making an incision in the lung area and inserting a tissue dilator and port into the incision.
  • a tissue core which includes the anchored lesion may be created.
  • the resection device 1100 may be used to create the tissue core, to ligate the tissue core and to seal the tissue core and sever it from the surrounding tissue as described hereinabove. The tissue core may then be removed from the channel.
  • a cavity port may be inserted in the channel to facilitate subsequent treatment of the target lesion site through chemotherapy and/or energy-based tumor extirpation such as radiation.
  • a cavity port may be disposed on the perimeter of the tissue resection apparatus. When the apparatus is removed from the tissue site, the cavity port may remain in place or may be removed.
  • the anchor depicted in Figure 5 is suitable for use in performing the method for removing tissue lesions described herein.
  • the anchor comprises an outer tube 1422 having a sufficiently sharp edge to pierce the chest cavity tissue and lung without causing excess damage and an inner tube 1424 disposed within the outer tube 1422.
  • One or more tines or fingers 1426 formed from shape memory material, e.g., Nitinol, preformed are attached to the end of the inner tube 1424.
  • the outer tube 1422 is retractably disposed over the inner tube 1424 such that when the outer tube 1422 is retracted, the tines 1426 assume their preform shape as shown.
  • the outer tube 1422 is retracted after it has pierced the lung lesion thereby causing the tines 1426 to engage the lung lesion.
  • Other suitable anchors may include coils and suction-based structures.
  • the incision blades depicted in Figure 6 are suitable for use in performing the method for removing tissue lesions described herein.
  • the anchor 1400 Once the anchor 1400 is set, it is preferable to create a small cut or incision to facilitate insertion of chest wall tissue dilator.
  • Incision blades 1605 are used to make a wider cut.
  • the incision blades 1605 may be successive and may include a central aperture which allows them to be coaxially advanced along the anchor needle 1405 to create a wider cut in the chest wall, with each successive blade being larger than the previous blade, thereby increasing the width of the incision.
  • the tissue dilator depicted in Figure 7 is suitable for use in performing the method for removing tissue lesions described herein.
  • the tissue dilator may comprise any suitable device for creating a channel in organic tissue.
  • the tissue dilator assembly includes a single cylindrical rod with a rounded end 1510 or a cylindrical rod with rounded end and a rigid sleeve arrangement 1515. Successive tissue dilators are coaxially advanced along the anchor needle to create tissue tract or channel in the chest wall, with each successive dilator being larger than the previous dilator, thereby increasing the diameter of the channel.
  • tissue resection device capable of penetrating lung tissue and creating a tissue core including a target lesion is suitable for use in performing the method for removing tissue lesions described herein.
  • the tissue resection device 1100 described herein is preferred.
  • tissue resection device 1100 Once the tissue resection device 1100 is removed, a small channel in the lung exists where the target lesion was removed. This channel may be utilized to introduce an energy- based ablation device and/or localized chemotherapy depending on the results of the tissue diagnosis. Accordingly, the method and system of the present disclosure may not only be utilized to ensure an effective biopsy is performed but also complete removal of the lesion with minimal healthy lung tissue removal.
  • FIG. 8 shows a flow diagram of an example method.
  • tissue at a target site may be cored such that a tissue core is removed from the target site thereby creating a core cavity at the target site.
  • Coring tissue at a target site may comprise transecting and sealing tissue.
  • Coring tissue at a target site may comprise disposing a tissue coring apparatus adjacent to a target tissue site.
  • the tissue coring apparatus may comprise a first clamping element comprising a helical coil, a second clamping element, the second clamping element being positioned to oppose at least a portion of the first clamping element, a first and second electrode configured for the delivery of radiofrequency energy for sealing tissue, and/or a cutting element configured for the transection of at least a portion of the sealed tissue.
  • Other apparatus may be used.
  • a tissue resection device may be disposed at a target tissue site.
  • the target tissue site may comprise a tissue lesion.
  • Various tissues may be comprised as the target site.
  • the tissue resection device may comprise one or more of the devices or components described herein.
  • a core of tissue may be resected.
  • a core of tissue may have a prescribed (e.g., pre-defined) shape (e.g., columnar) and dimension based on a coring apparatus.
  • Such coring apparatus may be used to core the same or substantially the same shaped tissue core in a repeatable manner.
  • Such coring may be distinguished from other tissue removal, for example using scissors or scalpel, where the cut tissue will not have a pre-defined shape or dimensions.
  • the tissue resection device may be caused to resect a core of tissue from the target tissue site.
  • the tissue resection device may be removed from that body or create a core cavity at the target tissue site. Since a core of tissue was removed, biological fluid may flow toward or into the core cavity.
  • At 1810 at least a portion of the core cavity may be sealed.
  • Such sealing may comprise sealing biological fluid vessels.
  • the sealing biological fluid vessels may minimize flow of biological fluids into the cavity core.
  • the present disclosure comprises at least the following aspects:
  • a tissue resection device configured for coring tissue, the device comprising: a first clamping element comprising a helical coil; a second clamping element, the second clamping element being positioned to oppose at least a portion of the first clamping element; a first electrode and a second electrode configured for the delivery of radiofrequency energy to an area adjacent one or more of the first clamping element and the second clamping element to seal tissue; and a cutting element configured for the transection of at least a portion of the sealed tissue.
  • Aspect 3 The tissue resection device of aspect 1, further comprising: a first actuator operable to actuate the first or second clamping element to apply mechanical compression to tissue; and a second actuator operable to actuate the cutting element to transect tissue.
  • Aspect 4 The tissue resection device of aspect 1, wherein the helical coil comprises first and second contiguous coil segments
  • Aspect 5 The tissue resection device of aspect 4, wherein the first coil segment comprises a generally planar open ring.
  • Aspect 6 The tissue resection device of aspect 5, wherein the first coil segment is helical and has a pitch of zero.
  • Aspect 7 The tissue resection device of aspect 4, wherein the second coil segment is helical and has a non-zero pitch.
  • Aspect 8 The tissue resection device of aspect 7, wherein the second coil segment has a variable pitch.
  • Aspect 9 The tissue resection device of aspect 4, wherein the first coil segment is helical and has a first pitch and the second coil segment is helical and has a second pitch, and at least one of the first and second pitches is variable.
  • Aspect 10 The tissue resection device of aspect 1, wherein the first electrode is provided by at least a portion of the first clamping element.
  • Aspect 11 The tissue resection device of aspect 1, wherein the second electrode is provided by at least a portion of the second clamping element.
  • Aspect 12 The tissue resection device of aspect 1, wherein the helical coil includes a blunt tip.
  • Aspect 13 The tissue resection device of aspect 1, wherein the first and second electrodes have surface profiles that are substantially matching.
  • Aspect 14 The tissue resection device of aspect 1, wherein at least a portion of the cutting element comprises a sharpened edge.
  • Aspect 15 The tissue resection device of aspect 1, wherein the cutting element comprises at least one electrode configured for the delivery of radiofrequency energy.
  • Aspect 16 The tissue resection device of aspect 1, wherein the cutting element comprises an ultrasonic blade.
  • Aspect 17 The tissue resection device of aspect 1, further comprising a second cutting element configured for the amputation the core of tissue from the target tissue site.
  • Aspect 18 The tissue resection device of aspect 17, wherein at least a portion of the second cutting element comprises a sharpened edge.
  • Aspect 19 The tissue resection device of aspect 17, wherein the second cutting element comprises at least one electrode configured for the delivery of radiofrequency energy.
  • Aspect 20 The tissue resection device of aspect 17, wherein the second cutting element comprises an energized wire.
  • Aspect 21 The tissue resection device of aspect 17, wherein the second cutting element comprises a suture.
  • Aspect 22 The tissue resection device of aspect 17, further comprising an actuator operable to actuate the second cutting element to transect tissue.
  • Aspect 23 A method for coring tissue, the method comprising: disposing a tissue resection device at a target tissue site; causing the tissue resection device to resect a core of tissue from the target tissue site; and removing the core of tissue from the body, wherein the removing the core of tissue from the body creates a core cavity at the target tissue site.
  • Aspect 24 The method of aspect 23, wherein the core of tissue comprises at least a portion of a tissue lesion.
  • Aspect 25 The method of aspect 23, further comprising disposing a sleeve to provide access to the target tissue site.
  • Aspect 26 The method of aspect 25, wherein the disposing the sleeve is implemented prior to the removing the core of tissue from the body.
  • Aspect 27 The method of aspect 25, wherein the disposing the sleeve is implemented after the removing the core of tissue from the body.
  • Aspect 28 The method of aspect 25, wherein the sleeve comprises a deployable trocar.
  • Aspect 29 The method of aspect 25, wherein the sleeve comprises electrodes that are configured to seal or ablate adjacent the target tissue site.
  • Aspect 30 The method of aspect 25, wherein the sleeve comprises radio frequency electrodes that are configured to seal or ablate adjacent the target tissue site using radiofrequency energy.
  • Aspect 31 The method of aspect 23, further comprising delivering radiofrequency energy to at least a portion of a wall defining the core cavity.
  • Aspect 32 The method of aspect 23, further comprising delivering chemotherapy to at least a portion of a wall defining the core cavity.
  • Aspect 33 The method of aspect 23, further comprising delivering microwave energy to at least a portion of a wall defining the core cavity.
  • Aspect 34 The method of aspect 23, further comprising delivering thermal energy to at least a portion of a wall defining the core cavity.
  • Aspect 35 The method of aspect 23, further comprising delivering ultrasonic energy to at least a portion of a wall defining the core cavity.
  • Aspect 36 The method of aspect 23, wherein the tissue resection device is configured for the delivery of radiofrequency energy.
  • Aspect 37 The method of aspect 23, wherein the tissue resection device is configured for mechanical transection.
  • Aspect 38 The method of aspect 23, wherein the tissue resection device is configured for mechanical compression and the delivery of radiofrequency energy.
  • Aspect 39 The method of aspect 23, wherein the resecting the core of tissue from the target tissue site comprises mechanical transection.
  • Aspect 40 The method of aspect 23, wherein the resecting the core of tissue from the target tissue site comprises the delivery of radiofrequency energy.
  • Aspect 41 The method of aspect 23, wherein the resecting the core of tissue from the target tissue site comprises mechanical compression and the delivery of radiofrequency energy.
  • Aspect 42 The method of aspect 23, wherein the resecting the core of tissue from the target tissue site comprises mechanical compression, the delivery of radiofrequency energy, and mechanical transection.
  • Aspect 43 The method of aspect 23, wherein the resecting the core of tissue from the target tissue site comprises transection with an energized wire.
  • Aspect 44 The method of aspect 23, further comprising sealing biological fluid vessels.
  • Aspect 45 The method of aspect 44, wherein the sealing biological fluid vessels minimizes flow of biological fluids into the cavity core.
  • Aspect 46 The method of aspect 44, wherein the sealing is effected using at least mechanical compression.
  • Aspect 47 The method of aspect 44, wherein the sealing is effected using at least radiofrequency energy.
  • Aspect 48 The method of aspect 44, wherein the sealing is effected using at least microwave energy.
  • Aspect 49 The method of aspect 44, wherein the sealing is effected using at least ultrasonic energy.
  • a method for coring tissue comprising: disposing a tissue resection device at a target tissue site, wherein the tissue resection device comprises: a first clamping element comprising a helical coil and a first electrode, and a second clamping element comprising a second electrode, the second clamping element being positioned to oppose at least a portion of the first clamping element; causing the tissue resection device to resect a core of tissue from the target tissue site; and removing the core of tissue from the body, wherein the removing the core of tissue from the body creates a core cavity at the target tissue site.
  • Aspect 51 The method of aspect 50, wherein the core of tissue comprises at least a portion of a tissue lesion.
  • Aspect 52 The method of aspect 50, further comprising inserting a sleeve into the core cavity to support a wall of the core cavity.
  • Aspect 53 The method of aspect 50, further comprising delivering radiofrequency energy to at least a portion of a wall defining the core cavity.
  • Aspect 54 The method of aspect 50, further comprising delivering chemotherapy to at least a portion of a wall defining the core cavity.
  • Aspect 55 The method of aspect 50, further comprising delivering microwave energy to at least a portion of a wall defining the core cavity.
  • Aspect 56 The method of aspect 50, further comprising delivering thermal energy to at least a portion of a wall defining the core cavity.
  • Aspect 57 The method of aspect 50, further comprising delivering ultrasonic energy to at least a portion of a wall defining the core cavity.
  • Aspect 58 The method of aspect 50, wherein the tissue resection device is configured for the delivery of radiofrequency energy.
  • Aspect 59 The method of aspect 50, wherein the tissue resection device is configured for mechanical transection.
  • Aspect 60 The method of aspect 50, wherein the tissue resection device is configured for mechanical compression and the delivery of radiofrequency energy.
  • Aspect 61 The method of aspect 50, wherein the resecting the core of tissue from the target tissue site comprises mechanical transection.
  • Aspect 62 The method of aspect 50, wherein the resecting the core of tissue from the target tissue site comprises the delivery of radiofrequency energy.
  • Aspect 63 The method of aspect 50, wherein the resecting the core of tissue from the target tissue site comprises mechanical compression and the delivery of radiofrequency energy.
  • Aspect 64 The method of aspect 50, wherein the resecting the core of tissue from the target tissue site comprises mechanical compression, the delivery of radiofrequency energy, and mechanical transection.
  • Aspect 65 The method of aspect 50, wherein the resecting the core of tissue from the target tissue site comprises transection with an energized wire.
  • Aspect 66 The method of aspect 50, further comprising sealing biological fluid vessels.
  • Aspect 67 The method of aspect 66, wherein the sealing biological fluid vessels minimizes flow of biological fluids into the cavity core.
  • Aspect 68 The method of aspect 66, wherein the sealing is effected using at least mechanical compression.
  • Aspect 69 The method of aspect 66, wherein the sealing is effected using at least radiofrequency energy.
  • Aspect 70 The method of aspect 66, wherein the sealing is effected using at least microwave energy.
  • Aspect 71 The method of aspect 66, wherein the sealing is effected using at least ultrasonic energy.
  • a method for sealing biological fluid vessels comprising: piercing a target tissue site with a helical tissue sealing mechanism, wherein the helical tissue sealing mechanism comprises: a helical piercing element; and at least one clamping element; applying mechanical compression to at least a portion of at least one target biological fluid vessel within the target tissue site; and causing the helical tissue sealing mechanism to seal at least one target biological fluid vessel.
  • Aspect 73 The method of aspect 72, wherein the helical piercing element comprises at least one clamping element.
  • Aspect 74 The method of aspect 72, wherein the applying mechanical compression is effected by adjusting the relative positions of the helical piercing element and the clamping element.
  • Aspect 75 The method of aspect 72, further comprising a second clamping element.
  • Aspect 76 The method of aspect 75, wherein the applying mechanical compression is effected by adjusting the relative positions of the first and second clamping elements.
  • Aspect 77 The method of aspect 72, wherein the sealing of at least one target biological fluid vessel minimizes flow of biological fluids through at least one target biological fluid vessel.
  • Aspect 78 The method of aspect 72, wherein the sealing is effected using at least mechanical compression.
  • Aspect 79 The method of aspect 72, wherein the sealing is effected using at least radiofrequency energy.
  • Aspect 80 The method of aspect 72, wherein the sealing is effected using at least microwave energy.
  • Aspect 81 The method of aspect 72, wherein the sealing is effected using at least ultrasonic energy.
  • a tissue resection device configured for coring tissue, the device comprising: a first clamping element having a helical coil disposed on a distal end; a second clamping element, the second clamping element being positioned to oppose at least a portion of the first clamping element; a first and second electrode configured for the delivery of radiofrequency energy, for example, for sealing tissue; and a cutting element configured for the transection of at least a portion of tissue at a target site, such as the sealed tissue.
  • Aspect 83 The tissue resection device of aspect 82, further comprising: a first actuator operable to actuate the first or second clamping element to apply mechanical compression to tissue; and a second actuator operable to actuate the cutting element to transect tissue.
  • Aspect 84 The tissue resection device of aspect 82, wherein the helical coil includes first and second contiguous coil segments.
  • Aspect 85 The tissue resection device of aspect 84, wherein the first coil segment comprises a generally planar open ring.
  • Aspect 86 The tissue resection device of aspect 85, wherein the first coil segment is helical and has a pitch of zero.
  • Aspect 87 The tissue resection device of aspect 84, wherein the second coil segment is helical and has a non-zero pitch.
  • Aspect 88 The tissue resection device of aspect 87, wherein the second coil segment has a variable pitch.
  • Aspect 89 The tissue resection device of aspect 84, wherein the first coil segment is helical and has a first pitch and the second coil segment is helical and has a second pitch, and at least one of the first and second pitches is variable.
  • Aspect 90 The tissue resection device of aspect 82, wherein the first electrode is provided by at least a portion of the helical coil.
  • Aspect 91 The tissue resection device of aspect 82, wherein the first electrode is provided by at least a portion of the first clamping element.
  • Aspect 92 The tissue resection device of aspect 82, wherein the second electrode is provided by at least a portion of the second clamping element.
  • Aspect 93 The tissue resection device of aspect 82, wherein the helical coil includes a blunt tip.
  • Aspect 94 The tissue resection device of aspect 82, wherein the first and second electrodes have surface profiles that are substantially matching.
  • Aspect 95 The tissue resection device of aspect 82, wherein at least a portion of the cutting element comprises a sharpened edge.
  • Aspect 96 The tissue resection device of aspect 82, wherein the cutting element comprises at least one electrode configured for the delivery of radiofrequency energy.
  • Aspect 97 The tissue resection device of aspect 82, wherein the cutting element comprises an ultrasonic blade.
  • Aspect 98 The tissue resection device of aspect 82, further comprising a second cutting element configured for the amputation the core of tissue from the target tissue site.
  • Aspect 99 The tissue resection device of aspect 98, wherein at least a portion of the second cutting element comprises a sharpened edge.
  • Aspect 100 The tissue resection device of aspect 98, wherein the second cutting element comprises at least one electrode configured for the delivery of radiofrequency energy.
  • Aspect 101 The tissue resection device of aspect 98, wherein the second cutting element comprises an energized wire.
  • Aspect 102 The tissue resection device of aspect 98, wherein the second cutting element comprises a suture.
  • tissue resection device of aspect 98 further comprising an actuator operable to actuate the second cutting element to transect tissue.
  • Aspect 104 The tissue resection device of aspect 82, further comprising: a first and second ligating element; and a second cutting element positioned between said first and second ligating elements.
  • Aspect 105 The tissue resection device of aspect 104, wherein the first and second ligating elements comprise a first and second ligating electrode configured for the delivery of radiofrequency energy.
  • Aspect 106 The tissue resection device of aspect 104, wherein second cutting element is configured to transect tissue between the first and second ligating elements.
  • tissue resection device of aspect 82 further comprising a snare element.
  • Aspect 108 The tissue resection device of aspect 107, wherein the snare element comprises a flexible line configured for the ligation of tissue.
  • Aspect 109 The tissue resection device of aspect 107, wherein the snare element comprises a flexible line configured for the transection of tissue.
  • Aspect 110 The tissue resection device of aspect 107, further comprising a circumferential grooved pathway, said snare element being disposed in the circumferential grooved pathway.
  • a tissue resection device configured for coring tissue, the device comprising: a first clamping element comprising a helical coil and a first electrode; and a second clamping element comprising a second electrode, the second clamping element being positioned to oppose at least a portion of the first clamping element, wherein the first and second clamping elements are configured for: (a) the delivery of radiofrequency energy for sealing tissue, and (b) the application of mechanical compression for the transection of tissue.
  • Aspect 112. The tissue resection device of aspect 111, further comprising an actuator operable to actuate the first or second clamping element to apply mechanical compression to tissue.
  • Aspect 113 The tissue resection device of aspect 111, wherein the helical coil includes first and second contiguous coil segments.
  • Aspect 114 The tissue resection device of aspect 113, wherein the first coil segment comprises a generally planar open ring.
  • Aspect 115 The tissue resection device of aspect 114, wherein the first coil segment is helical and has a pitch of zero.
  • Aspect 116 The tissue resection device of aspect 113, wherein the second coil segment is helical and has a non-zero pitch.
  • Aspect 117 The tissue resection device of aspect 116, wherein the second coil segment has a variable pitch.
  • Aspect 118 The tissue resection device of aspect 113, wherein the first coil segment is helical and has a first pitch and the second coil segment is helical and has a second pitch, and at least one of the first and second pitches is variable.
  • Aspect 119 The tissue resection device of aspect 111, wherein the first electrode is provided by at least a portion of the helical coil.
  • Aspect 120 The tissue resection device of aspect 111, wherein the helical coil includes a blunt tip.
  • Aspect 121 The tissue resection device of aspect 111, wherein the first and second clamping elements have surface profiles that are substantially matching.
  • Aspect 122 The tissue resection device of aspect 111, further comprising a cutting element.
  • Aspect 123 The tissue resection device of aspect 122, wherein at least a portion of the cutting element comprises a sharpened edge.
  • Aspect 124 The tissue resection device of aspect 122, wherein the cutting element comprises at least one electrode configured for the delivery of radiofrequency energy.
  • Aspect 125 The tissue resection device of aspect 122, wherein the cutting element comprises an ultrasonic blade.
  • Aspect 126. The tissue resection device of aspect 122, further comprising a second cutting element configured for the amputation the core of tissue from the target tissue site.
  • Aspect 127 The tissue resection device of aspect 126, wherein at least a portion of the second cutting element comprises a sharpened edge.
  • Aspect 128 The tissue resection device of aspect 126, wherein the second cutting element comprises at least one electrode configured for the delivery of radiofrequency energy.
  • Aspect 129 The tissue resection device of aspect 126, wherein the second cutting element comprises an energized wire.
  • tissue resection device of aspect 126 further comprising an actuator operable to actuate the second cutting element to transect tissue.
  • a tissue sealing mechanism comprising: a helical coil with a generally obround cross section and a tapered point disposed at a distal end; a first and second helical tissue sealing surface, wherein the first and second helical tissue sealing surfaces are provided by the parallel planar surfaces of the helical coil; a first electrode disposed on the first helical tissue sealing surface; and a second electrode disposed on the second helical tissue sealing surface, wherein the first and second electrodes are configured to apply bipolar radiofrequency energy for sealing tissue.
  • Aspect 132 The tissue sealing mechanism of aspect 131, wherein the helical coil includes first and second contiguous coil segments.
  • Aspect 133 The tissue sealing mechanism of aspect 131, wherein the helical coil includes a blunt tip.
  • Aspect 134 The tissue sealing mechanism of aspect 131, wherein the first and second electrodes have surface profiles that are substantially matching.
  • Aspect 135. The tissue sealing mechanism of aspect 131, wherein the first and second helical tissue sealing surfaces further comprise a plurality of electrodes configured for the delivery of bipolar radiofrequency energy.

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Plasma & Fusion (AREA)
  • Otolaryngology (AREA)
  • Surgical Instruments (AREA)
  • Prostheses (AREA)

Abstract

L'invention concerne un procédé d'élimination de tissus, pouvant comprendre de disposer un dispositif de résection de tissu au niveau d'un site tissulaire cible, d'amener le dispositif de résection de tissu à effectuer une résection d'un noyau de tissu à partir du site de tissu cible, de retirer le noyau de tissu du corps, le retrait du noyau de tissu du corps créant une cavité de noyau au niveau du site de tissu cible.
PCT/IB2021/053588 2020-04-30 2021-04-29 Systèmes, dispositifs et procédés de carottage de tissu WO2021220220A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
BR112022022100A BR112022022100A2 (pt) 2020-04-30 2021-04-29 Sistemas, dispositivos e métodos para extração de tecido
KR1020227042125A KR20230005959A (ko) 2020-04-30 2021-04-29 조직을 코어링하기 위한 시스템, 장치 및 방법
CN202180032065.2A CN116528780A (zh) 2020-04-30 2021-04-29 用于取芯组织的系统、装置和方法
JP2022566610A JP2023545883A (ja) 2020-04-30 2021-04-29 組織をコア除去するシステム、装置、及び方法
EP21723409.5A EP4132388A1 (fr) 2020-04-30 2021-04-29 Systèmes, dispositifs et procédés de carottage de tissu
CA3177320A CA3177320A1 (fr) 2020-04-30 2021-04-29 Systemes, dispositifs et procedes de carottage de tissu

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063017724P 2020-04-30 2020-04-30
US63/017,724 2020-04-30

Publications (1)

Publication Number Publication Date
WO2021220220A1 true WO2021220220A1 (fr) 2021-11-04

Family

ID=75787172

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2021/053588 WO2021220220A1 (fr) 2020-04-30 2021-04-29 Systèmes, dispositifs et procédés de carottage de tissu

Country Status (7)

Country Link
EP (1) EP4132388A1 (fr)
JP (1) JP2023545883A (fr)
KR (1) KR20230005959A (fr)
CN (1) CN116528780A (fr)
BR (1) BR112022022100A2 (fr)
CA (1) CA3177320A1 (fr)
WO (1) WO2021220220A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022214896A1 (fr) * 2021-04-09 2022-10-13 Ethicon, Inc. Systèmes, dispositifs et procédés de carottage de tissu
US12102372B2 (en) 2018-07-31 2024-10-01 Prana Thoracic, Inc. Tissue resection apparatus

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5133360A (en) * 1991-03-07 1992-07-28 Spears Colin P Spears retriever
US20050113854A1 (en) * 2003-11-25 2005-05-26 Uckele John E. Cervical conization device
US20170042516A1 (en) * 2005-07-26 2017-02-16 Edward M. Boyle, JR. Minimally invasive methods and apparatus
US20180140319A1 (en) * 2016-11-23 2018-05-24 Iyad Saidi Apparatus and methods for tissue reduction
EP3603546A1 (fr) * 2018-07-31 2020-02-05 Ethicon, Inc. Kit pour l'élimination d'une lésion tissulaire

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5133360A (en) * 1991-03-07 1992-07-28 Spears Colin P Spears retriever
US20050113854A1 (en) * 2003-11-25 2005-05-26 Uckele John E. Cervical conization device
US20170042516A1 (en) * 2005-07-26 2017-02-16 Edward M. Boyle, JR. Minimally invasive methods and apparatus
US20180140319A1 (en) * 2016-11-23 2018-05-24 Iyad Saidi Apparatus and methods for tissue reduction
EP3603546A1 (fr) * 2018-07-31 2020-02-05 Ethicon, Inc. Kit pour l'élimination d'une lésion tissulaire

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12102372B2 (en) 2018-07-31 2024-10-01 Prana Thoracic, Inc. Tissue resection apparatus
WO2022214896A1 (fr) * 2021-04-09 2022-10-13 Ethicon, Inc. Systèmes, dispositifs et procédés de carottage de tissu

Also Published As

Publication number Publication date
KR20230005959A (ko) 2023-01-10
BR112022022100A2 (pt) 2023-03-07
CA3177320A1 (fr) 2021-11-04
CN116528780A (zh) 2023-08-01
JP2023545883A (ja) 2023-11-01
EP4132388A1 (fr) 2023-02-15

Similar Documents

Publication Publication Date Title
US12102372B2 (en) Tissue resection apparatus
US11723708B2 (en) Method for removing a tissue lesion
EP3603546B1 (fr) Kit pour l'élimination d'une lésion tissulaire
US20210219967A1 (en) Systems, devices, and methods for coring tissue
US20210338265A1 (en) Methods and devices for delivering cancer therapy to a target tissue site via a cored tissue cavity
WO2021220220A1 (fr) Systèmes, dispositifs et procédés de carottage de tissu
US20210338315A1 (en) Systems and methods for sealing cored or punctured tissue using fill material
WO2022214896A1 (fr) Systèmes, dispositifs et procédés de carottage de tissu
US20220047322A1 (en) Coring and amputation devices, systems, and methods
US20210338316A1 (en) Systems and methods for sealing cored or punctured tissue using inflatable balloon
US20210338218A1 (en) Systems and methods for sealing cored or punctured tissue
US20210338215A1 (en) Tissue resection systems and methods for diagnostic and therapeutic implementation
BR102019015643A2 (pt) método para remover uma lesão de tecido

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21723409

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2022566610

Country of ref document: JP

Kind code of ref document: A

Ref document number: 3177320

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 202180032065.2

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 202217065451

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2021723409

Country of ref document: EP

Effective date: 20221110

ENP Entry into the national phase

Ref document number: 20227042125

Country of ref document: KR

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112022022100

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112022022100

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20221031